ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,180Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 307

$825K Total Retail Price of All Prescriptions

Rank: 6 out of 307

436 Patients Receiving at Least One Drug in Part D
41%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 436 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 4,572 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 520 269 1 2
LEVOTHYROXINE SODIUM 413 179 2 1
LISINOPRIL 333 149 3 3
HYDROCODONE-ACETAMINOPHEN 330 105 S3 4 4
AMLODIPINE BESYLATE 229 135 5 7
OMEPRAZOLE 229 88 5 5
METFORMIN HCL 204 118 7 8
CYMBALTA 199 83 8 30
GABAPENTIN 191 30 9 15
FUROSEMIDE 160 91 10 6
ATORVASTATIN CALCIUM 156 69 11 18
HYDROCHLOROTHIAZIDE 153 116 12 9
NEXIUM 139 70 13 38
ATENOLOL 127 77 14 17
JANUVIA 124 56 15 97
METOPROLOL TARTRATE 119 59 16 12
LOSARTAN POTASSIUM 116 93 17 16
ADVAIR DISKUS 116 65 17 28
TRAMADOL HCL 107 46 19 25
TIZANIDINE HCL 106 22 20 99
PROAIR HFA 104 19 21 53
TRAZODONE HCL 102 35 22 33
METFORMIN HCL ER 98 52 23 52
MIRTAZAPINE 98 24 23 51
CITALOPRAM HBR 96 45 25 14
PANTOPRAZOLE SODIUM 95 29 26 49
OXYCODONE HCL 94 32 S2 27 31
BUSPIRONE HCL 84 66 28 103
ACTOS 82 40 29 93
METOPROLOL SUCCINATE 82 31 29 13
ALENDRONATE SODIUM 80 44 31 20
TAMSULOSIN HCL 78 30 32 21
MORPHINE SULFATE ER 70 0 S2 33 56
CYCLOBENZAPRINE HCL 70 27 R 33 75
VENLAFAXINE HCL ER 68 29 35 88
SPIRIVA 64 44 36 48
SERTRALINE HCL 64 30 36 22
POTASSIUM CHLORIDE 62 52 38 10
LANTUS 62 22 38 47
SINGULAIR 61 25 40 100
VENTOLIN HFA 60 30 41 98
BISOPROLOL FUMARATE 59 20 42 210
DETROL LA 58 36 43 156
MELOXICAM 57 17 44 29
PEN NEEDLE 57 0 44 128
AMITRIPTYLINE HCL 56 20 R 46 65
OXYCODONE-ACETAMINOPHEN 55 22 S2 47 63
LYRICA 54 13 48 82
PRAVASTATIN SODIUM 54 42 48 26
ROPINIROLE HCL 52 0 50 74
KLOR-CON M20 51 20 51 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.